ICMR chief justifies emergency approval citing safety & immunogenicity

Even as the Covid-19 vaccine is likely to arrive in Delhi by early next week, restricted emergency use of vaccines is considered based on safety and immunogenicity data, said Indian Council of Medical Research (ICMR) chief Balram Bhargava. Continue Reading

Covid: Centre says it may not vaccinate whole country

Even as speculation is rife regarding the availability of a Covid-vaccine in the country, Union Health Secretary Rajesh Bhushan has stated that the government is not considering the option of vaccinating the whole population. Continue Reading

DCGI gives nod to Serum Institute for phase 2, 3 human clinical trials of Oxford vaccine

The Drugs Controller General of India (DCGI) has given nod to the Serum Institute of India (SII) for conducting phase 2 and 3 human clinical trials of the Oxford University developed Covid-19 vaccine candidate in the country. Continue Reading